Cardiovascular Devices Market
Description
Cardiovascular devices are medical devices used to diagnose and treat heart disease and related health problems. Cardiovascular devices, such as cardiac implantable electronic devices, designed to help control or monitor irregular heartbeats in people with certain heart rhythm disorders and heart failure. More people worldwide are using ECGs for diagnostic and monitoring purposes. An ECG is often used alongside other tests to help diagnose and monitor conditions affecting the heart. There are several types of devices available.
Market Dynamics
High prevalence of cardiovascular diseases, growing geriatric population, increase in demand for cardiovascular devices, technological advances, rise in research and development, and introduction of novel products by market players are major factors expected to propel the growth of the global cardiovascular devices market over the forecast period.
For instance, in October 2022, Medtronic plc received the US FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods.
Moreover, in October 2022, Biosense Webster, Inc. launched the HELIOSTAR Balloon Ablation Catheter in Europe. HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.
Key features of the study
Market Dynamics
High prevalence of cardiovascular diseases, growing geriatric population, increase in demand for cardiovascular devices, technological advances, rise in research and development, and introduction of novel products by market players are major factors expected to propel the growth of the global cardiovascular devices market over the forecast period.
For instance, in October 2022, Medtronic plc received the US FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods.
Moreover, in October 2022, Biosense Webster, Inc. launched the HELIOSTAR Balloon Ablation Catheter in Europe. HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.
Key features of the study
- This report provides in-depth analysis of the global cardiovascular devices market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cardiovascular devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Livanova PLC, B. Braun Melsungen AG, Edwards Lifesciences, Biotronik, Medtronic PLC, GE Healthcare, Cardinal Health Inc., Abbott Laboratories, Siemens Healthineers AG, WL Gore & Associates Inc., Boston Scientific Corporation, and Canon Medical Systems Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cardiovascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiovascular devices market.
- Global Cardiovascular Devices Market, By Device Type
- Diagnostic and Monitoring Devices
- Therapeutic and Surgical Devices
- Global Cardiovascular Devices Market, By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Livanova PLC
- Braun Melsungen AG
- Edwards Lifesciences
- Biotronik
- Medtronic PLC
- GE Healthcare
- Cardinal Health Inc.
- Abbott Laboratories
- Siemens Healthineers AG
- WL Gore & Associates Inc.
- Boston Scientific Corporation
- Canon Medical Systems Corporation
Table of Contents
160 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in prevalence of cardiovascular diseases worldwide
- High cost of cardiovascular devices and cardiac procedures
- Increase in demand for cardiovascular devices worldwide
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Cardiovascular Devices Market, By Device Type, 2020-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- Diagnostic and Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
- Therapeutic and Surgical Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
- 5. Global Cardiovascular Devices Market, By Geography, 2020-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 – 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020-2033,(USD Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020-2033,(USD Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020-2033,(USD Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020-2033,(USD Mn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020-2033,(USD Mn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020-2033,(USD Mn)
- 6. Competitive Landscape
- Livanova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- B. Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Edwards Lifesciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardinal Health Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WL Gore & Associates Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
- 7. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on Global Cardiovascular Devices Market” - forecast to 2033
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



